A detailed history of Graham Capital Management, L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Graham Capital Management, L.P. holds 30,690 shares of TEVA stock, worth $677,942. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,690
Previous 36,931 16.9%
Holding current value
$677,942
Previous $600,000 7.83%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $98,670 - $118,329
-6,241 Reduced 16.9%
30,690 $553,000
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $1.39 Million - $1.89 Million
-108,899 Reduced 74.68%
36,931 $600,000
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $80,686 - $109,119
7,562 Added 5.47%
145,830 $2.06 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $1.12 Million - $1.47 Million
138,268 New
138,268 $1.44 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.